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Nephropathy documented by renal biopsy in 13 patients with cystic 
fibrosis 
Y. Yahaoui 1, D. Hubert 2, L.H. Nogl 1, C. Amrein ~, M. Stern 4, R. Guillemain 3,D. 
Chauveau 1 
~service de n@hrologie H3pitaI Necker; 2service de pneumologie H3pitaI Cochin, 
3service de chirurgie carffio-vasculaire HEGP, 4semite de pneumologie HbpitaI 
Foch, Paris, Fratwe 
The aim of our study was to evaluate the clinical and pathological features of renal 
disease documented by renal biopsy in patients with CF. 
Thirteen patients, aged 16 49 years, tmderwent a renal biopsy in the Ile de France 
area between 1992 and 2CO4. Twelve had pancreatic insufficiency, 8 diabetes and 6 
liver cirrhosis. Reasons for diaguosis of nephropathy were proteinuria ha 9 patients 
and increase ha serum creatinine ha 4 patients. 
Renal biopsy showed 5 diabetic nephropathies, 5 other glomerular diseases (2 
nepbr osis, one amyloidosis, one post infectious glomerulonepbritis, one rhumat oid 
purpur a nephritis), 2 nephr opathies econdary to the immunosuppressive tr atment 
and one oxalosis. 
Four patients had received lung and liver transplantation mad one liver 
transplantation before the onset of nephropathy. Four patients received lung 
transplantation and one lung and liver transplantation after the diaguosis of 
nephr opathy. Renal function worsened in 9 of 10 patients after transplantation. 
Total remission of nephropathy was observed in 2 patients (after acute 
glomemlonephritis and nephr osis). Isolated proteinuria remained in 2 patients. Two 
patients died of acute lung rejection with acute renal failure after transplantation. 
The 7 other patients developed cbronic renal ins~afficiency, 4 requiring periodic 
haemodialysis. Two of them died of septicaemia nd one successfully received 
kidney transplantation. 
In conclusion, nephr opathy can develop ha adult patients with CF, mainly in case of 
diabetes and/or liver citlhosis. In these patients, renal ins~afficiency worsens 
proguosis after lung transplantation. 
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Patients knowledge of sodium supplementation in one adult CF 
centre 
S. Pandy a, J. CYawley, M.J. Ledson, M.J. Walshaw 
RegionaI AduIt CF Unit, The Carffiothoracic Centre, Liverpool, UK 
Introduction. Salt depletion can occur in CF, particularly where patients are exposed 
to the sun or physical exertion to cause increased sweating. We had the impression 
that many of our adult patients had poor knowledge of this, and did not use sodium 
supplementation appropriately. We therefore conducted a survey to investigate his 
in our large CF trait. 
Methods. We surveyed 51 patients (mean age 23 years, 27 male) attending our large 
CF unit. 
Results. Two patients (4%) had been hospitalized after foreign travel due to severe 
dehydration. Only 30 (59%) understood the relationship between sodium mad CF. 
15 (29%) had never taken sodium supplements, even though 2 of these (12 %) 
understood the relationship. O1" the 36 patients (71%) who had taken sodium 
supplements, 7 patients (19%) were not currently doing so, 4 (8%) were taking daily 
supplements (2 at variable doses) and 18 (35%) only when the weather was hot in 
the UK and 25 (49%) during foreign travel. Additionally, 2 patients (4%) took 
supplements during vigorous exercise. As regards dosing, 24 (47%) did not know 
what they took, 3 (6%) knew the supplement and dose, 8 (16%) knew the 
supplement but not the dose mad 1 (2%) took their own supplement from a health 
food store. 28 patients (55%) put extra salt on their food, but only 1 patient was told 
to add it as part of their treatment. 
Conclusions. Thus, we have found considerable variability ha the knowledge of salt 
loss and sodium supplementation in our CF patients and are currently producing 
written information and guidelines to cotTcect this. 
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Sodium supplementation pracSce in the UK 
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Introduction We found that our adult CF patients have limited knowledge regarding 
salt depletion in CF, leading us to review our supplementation policy. We looked at 
the practice in a proportion of other UK centres. 
Methods We surveyed CF nurse specialists and dieticians, regarding sodium 
supplementation guidelines, incidence of sodium depletion, and use of extra dietary 
salt. 
Paediatric Centres (11/30) 
Although 10 (90%) advised supplements hahot weather/foreign travel and 5 (45%) 
during exercise, only 5 (45 %) had written guidelines, including the use of diar olyte 
(2 centres) and age/weight dependant doses of sodium chloride (3). Salt depletion 
syndromes had been seen in 5 (45%). 9 (82%) advised extra dietary salt, particularly 
for intolerance of supplements. Overall, the proportion of treated patients were: no 
patients (1 centre), 1 3% (1), 25 66% (1), all <1 year old (1), all until transfer to the 
adult sector (1), all during the summer (1), and variable numbers (5). 
Adult Centres (20/28) 
Although 17 (85%) recommended supplementation in hot weatherfforeign travel, 
only 5 (25%) recommended it during exercise (depending on type and intensity), 
and only 3 (15%) had written guidelines. 
Salt depletion syndromes had been seen in 7(35%). 11 (55%) did not know the dose 
or type of sodium preparation used, but 9 (45%) used slow sodium 6(~mg 2 6 
tablets daily (in 1 combined with diarolyte). 8 (40%) advised extra dietary salt. 
Proportions of patients on sodium supplements varied greatly (0 70% dependant on
the time of year). 
Conclusion There is great variation ha sodium supplementation use ha the UK, 
although most centres recommend ha hot weather and for foreign travel. There is a 
need for clear written national guidelines and protceols for the use of sodium 
supplementation in the CF community. 
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Meconium Ileus, alkalosis and early lung and heart involvement in a 
Bulgarian G85/AF cystic fibrosis patient 
I. Galeva 1, A. Kufardjieva 1,S. Mileva 1, A. Savoy ~ 
~Pediatric Clinic, Alexander's State Univemity Hospital, Sofia, 2L boratory of 
Molecular Patku~logy, Medical University, Sofia 
Aims: The findings of the European investigation on 68 CF patients with G85E were 
published last year and two Bulgarian CF patients (G85E/AF and G85E/?) were 
included in it. The res~alts showed that in 4 out of 31 CF (G85E/AF) the disease 
started with meconinm ileus (12.90%). No cases with alkalosis, neither with heart 
involvement were mentioned. 
Methods arm Results: Our third patient is a 5m old boy, second child in a young 
Bulgarian family. The pregnancy was followed cotrectly and the delivery after 36 
week of pregnancy was registered as "normal" (birth weight 2650gr, birth length 
49cm). 24h later the child was operated for meconium ileus. A resection of ~ 20 cm 
of the intestine and a temporary enterostoma were done. The CF diagnosis was 
made based on the hystopathological intestine findings, the sweat chloride 
concentration levels (up to 125 mmoFL) and the G85E/AF genotype. The patient 
was admitted in the hospital because of severe lung function impairment when he 
was 2 months old. Although the serum electrolyte concentrations were ha the normal 
range, a severe alkalosis (up to pH 7.58, BE +40.9, SB 61.0), a very low oxygen 
saturation and elevated PaCO2 were established. The aggressive and long lasting 
treatment with intravenous antibiotics, Saline solution, Aminoplasmal, Human 
plasma and glucose infusions, Vit C, pancreatic enzymes, corticosteroids, oxygen, 
inhaled br onchodilatat or s etc., improved the lung function as well as the gain weight 
51COgr. But the alkalosis persisted the optimal evels: pH 7.50, BE +23.2. 
An acute heart failure was observed at his 5m of age. The severe nlargement of the 
heart on the X ray chest examination was found and the patient has died a day later. 
Conclusions: The G 85E/AF genotype might severely disturb the cells metabolic 
function. 
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